Weixin Dai

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 2

Top Topics

Nlrp Inflammasome

Top Venues

Therapeutics and clinical risk management

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Heng Rong, Weixin Dai, Yinying Qin, Zhikeng Meng, Xia Zou, Binbin Wang, Qiufeng Wei, Yu-Bo Xie
Ultrasonographic Assessment of Gastric Volume in Fasted Patients Undergoing Gastrointestinal Endoscopy Under Sedation. Therapeutics and clinical risk management 19 (2023)
Min Shi, Jing Chen, Tianxiao Liu, Weixin Dai, Zhan Zhou, Lifei Chen, Yu-Bo Xie
Protective Effects of Remimazolam on Cerebral Ischemia/Reperfusion Injury in Rats by Inhibiting of NLRP3 Inflammasome-Dependent Pyroptosis. Drug design, development and therapy 16 (2022)